![](https://acino.com.sa/wp-content/themes/acinoTf/media/ims/placeholders/xplaceholder-news-archive.png.pagespeed.ic.xsNf3-5Xf2.png)
15.02.2017
Appointment of Mario Ricard as COO and member of the Executive Committee
Acino announces the appointment of Mario Ricard as Chief Operations Officer and member of the Executive Committee effective February 15,...
Acino announces the appointment of Mario Ricard as Chief Operations Officer and member of the Executive Committee effective February 15,...
Acino and Takeda announced today that Acino will acquire Takeda’s manufacturing site in Põlva, Estonia.The packaging site in Estonia is...
Acino today announced that it has completed the acquisition of the MENA operations and product rights for MOVICOL®, MOVIPREP®, KLEAN-PREP® and...
Acino International announces today the appointment of Kalle Känd as Chief Executive Officer Acino Group as of April 19, 2016....
Effective October 1, 2015, Acino Pharma, an international pharmaceutical company headquartered in Switzerland, acquires Pharma Start, the 9th largest local...
Acino’s rivastigmine patch is the first generic alternative to the originator product making the medical treatment of Alzheimer’s more affordable...